Literature DB >> 31172131

Sample Size Calculation Guide - Part 3: How to Calculate the Sample Size for an Independent Case-control Study.

Nadien Khaled Fahim1, Ahmed Negida2, Ahmed Khaled Fahim3.   

Abstract

Entities:  

Year:  2019        PMID: 31172131      PMCID: PMC6548115          DOI: 10.22114/AJEM.v0i0.138

Source DB:  PubMed          Journal:  Adv J Emerg Med        ISSN: 2588-400X


× No keyword cloud information.

INTRODUCTION

In the previous educational articles, we explained how to calculate the sample size for a rate or a single proportion and how to calculate the sample size for an independent cohort study (1, 2). In this article, we will explain how to calculate the sample size for an independent case-control study based on the odds ratios or two proportions representing the exposure rates in the case and the control groups.

WHEN TO USE THE SAMPLE SIZE CALCULATION PROCEDURE OF TWO PROPORTIONS

The methods explained hereafter should be used in the case that the primary outcome of your research study is expressed as odds ratio (OR) or two proportions. Although ORs are mainly obtained from case-control studies, other research designs might follow the same scenario if the primary outcome is a comparison of two proportions that will be represented as OR. Some prospective clinical trials report ORs to describe rare events. For example, a retrospective case-control study to evaluate the association between occupational lead exposure and kidney cancer. In this study, two groups of kidney cancer (cases) and healthy individuals (controls) are compared in terms of their history of occupational exposure to lead; the odds of lead exposure between in the two groups are expressed as OR. Epi Info main menu STATCALC menu Calculated result

REQUIREMENTS FOR SAMPLE SIZE CALCULATION BASED ON OR OR TWO PROPORTIONS FOR A CASE-CONTROL STUDY

(1) Expected OR: between exposed and non-exposed groups* (2) The probability of exposure in cases* (3) The probability of exposure in controls (4) Statistical power: 0.8, 0.85, or 0.9 (5) Alpha: usually 0.05 (6) Number of controls per subject in the cases group (1 in case of equal groups) * Either the OR or the probability of exposures in the cases will be needed.

EXAMPLE: A CASE-CONTROL STUDY ABOUT THE ASSOCIATION BETWEEN HCV INFECTION AND ORAL LICHEN PLANUS

Assume that we will conduct a case-control study to investigate the association between HCV infection and Oral Lichen Planus (OLP). Therefore, we will identify two groups from the population (cases: patients with OLP and control group: subjects without OLP). A previous study by Manomaivat et al. showed that the odds ratio of association between exposure to HCV infection and developing OLP was 9.7 with a 1/101 prevalence rate of HCV among the control group (healthy population) (3). The following steps will show how to calculate the sample size for a case-control study in order to detect a similar odds ratio with 90% statistical power and a 5% margin of error. Calculations will be done by the Epi Info, a program developed by the Centers for Disease Control and Prevention available via the link: https://www.cdc.gov/epiinfo/index.html First, open the software then select “STATCALC” for sample size calculation options (Figure 1). Then, select “unmatched case-control studies” (Figure 2). Finally, submit the data and check the table for the calculation results. As shown in Figure 3, the results table shows a sample size of 362 participants corresponding with a 95% confidence level. Therefore, the sample size calculation required for this study will be 362 patients (181 patients per group).
Figure 1

Epi Info main menu

Figure 2

STATCALC menu

Figure 3

Calculated result

  3 in total

1.  Association between hepatitis C infection in Thai patients with oral lichen planus: A case-control study.

Authors:  Trin Manomaivat; Surawut Pongsiriwet; Chatsri Kuansuwan; Wacharaporn Thosaporn; Kathawut Tachasuttirut; Anak Iamaroon
Journal:  J Investig Clin Dent       Date:  2018-01-18

2.  Sample Size Calculation Guide - Part 1: How to Calculate the Sample Size Based on the Prevalence Rate.

Authors:  Nadien Khaled Fahim; Ahmed Negida
Journal:  Adv J Emerg Med       Date:  2018-07-31

3.  Sample Size Calculation Guide - Part 2: How to Calculate the Sample Size for an Independent Cohort Study.

Authors:  Nadien Khaled Fahim; Ahmed Negida
Journal:  Adv J Emerg Med       Date:  2018-09-13
  3 in total
  7 in total

1.  Is there any association between adherence to the Mediterranean Diet and Dietary Total Antioxidant Capacity with Bacterial Vaginosis? Results from a Case-Control study.

Authors:  Morvarid Noormohammadi; Ghazaleh Eslamian; Seyyedeh Neda Kazemi; Bahram Rashidkhani
Journal:  BMC Womens Health       Date:  2022-06-20       Impact factor: 2.742

2.  Association between dietary patterns and bacterial vaginosis: a case-control study.

Authors:  Morvarid Noormohammadi; Ghazaleh Eslamian; Seyyedeh Neda Kazemi; Bahram Rashidkhani
Journal:  Sci Rep       Date:  2022-07-16       Impact factor: 4.996

3.  Mycoplasma pneumoniae Genotypes and Clinical Outcome in Children.

Authors:  Christoph Berger; Roger Dumke; Patrick M Meyer Sauteur; Elena Pánisová; Michelle Seiler; Martin Theiler
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

4.  Sample Size Calculation Guide - Part 4: How to Calculate the Sample Size for a Diagnostic Test Accuracy Study based on Sensitivity, Specificity, and the Area Under the ROC Curve.

Authors:  Ahmed Negida; Nadien Khaled Fahim; Yasmin Negida
Journal:  Adv J Emerg Med       Date:  2019-05-19

5.  Sample Size Calculation Guide - Part 5: How to calculate the sample size for a superiority clinical trial.

Authors:  Ahmed Negida; Nadien Khaled Fahim; Yasmin Negida; Hussien Ahmed
Journal:  Adv J Emerg Med       Date:  2019-08-29

6.  Sample Size Calculation Guide - Part 7: How to Calculate the Sample Size Based on a Correlation.

Authors:  Ahmed Negida
Journal:  Adv J Emerg Med       Date:  2020-02-17

7.  Sample Size Calculation Guide - Part 6: How to calculate the sample size for a non-inferiority or an equivalence clinical trial.

Authors:  Ahmed Negida
Journal:  Adv J Emerg Med       Date:  2019-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.